Evidence map›Paper›PMID 32019174›Full record

ArticleInternational journal of molecular sciences2020

In Vitro Evaluation of Different Prebiotics on the Modulation of Gut Microbiota Composition and Function in Morbid Obese and Normal-Weight Subjects.

Alicja M Nogacka, Nuria Salazar, Silvia Arboleya, Patricia Ruas-Madiedo, Leonardo Mancabelli, Adolfo Suarez, Ceferino Martinez-Faedo, Marco Ventura, Takumi Tochio, Katsuaki Hirano and 3 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Propionate and butyrate counteract renal damage and progression to chronic kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Article
  6. Potential Prebiotic Effects ofFoods (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Frontiers in microbiology · 2021
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Alicja M NogackaDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), 33300 Villaviciosa, Asturias, Spain.ORCID 0000-0001-8300-6149
Nuria SalazarDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), 33300 Villaviciosa, Asturias, Spain.
Silvia ArboleyaDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), 33300 Villaviciosa, Asturias, Spain.ORCID 0000-0002-6155-5822
Patricia Ruas-MadiedoDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), 33300 Villaviciosa, Asturias, Spain.ORCID 0000-0001-6158-9320
Leonardo MancabelliLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, 43121 Parma, Italy.
Adolfo SuarezDiet, Human Microbiota and Health Group, Institute of Health Research of the Principality of Asturias (ISPA), 33011 Oviedo, Spain.
Ceferino Martinez-FaedoEndocrinology and Nutrition Service, Central University Hospital of Asturias (HUCA), 33011 Oviedo, Asturias, Spain.
Marco VenturaLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, 43121 Parma, Italy.
Takumi Tochioβ-Food Sciences Co., Chita 478-0046, Japan.
Katsuaki Hiranoβ-Food Sciences Co., Chita 478-0046, Japan.
Akihito EndoDepartment of Food and Cosmetic Science, Tokyo University of Agriculture, Abashiri 099-2493, Japan.
Clara G de Los Reyes-GavilánDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), 33300 Villaviciosa, Asturias, Spain.ORCID 0000-0001-9396-6311
Miguel GueimondeDepartment of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), 33300 Villaviciosa, Asturias, Spain.ORCID 0000-0002-0192-901X
Instituto de Productos Lácteos de Asturias · ESHospital Universitario Central de Asturias · ESJapan Food Research Laboratories · JPUniversity of Parma · ITTokyo University of Agriculture · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota remains relatively stable during adulthood; however, certain intrinsic and environmental factors can lead to microbiota dysbiosis. Its restoration towards a healthy condition using best-suited prebiotics requires previous development of in vitro models for evaluating their functionality. Herein, we carried out fecal cultures with microbiota from healthy normal-weight and morbid obese adults. Cultures were supplemented with different inulin-type fructans (1-kestose, Actilight, P95, Synergy1 and Inulin) and a galactooligosaccharide. Their impact on the gut microbiota was assessed by monitoring gas production and evaluating changes in the microbiota composition (qPCR and 16S rRNA gene profiling) and metabolic activity (gas chromatography). Additionally, the effect on the bifidobacterial species was assessed (ITS-sequencing). Moreover, the functionality of the microbiota before and after prebiotic-modulation was determined in an in vitro model of interaction with an intestinal cell line. In general, 1-kestose was the compound showing the largest effects. The modulation with prebiotics led to significant increases in the

Indexed as

AdultBacteriaCase-Control StudiesFecesFemaleGastrointestinal MicrobiomeHumansIn Vitro TechniquesMaleObesity, MorbidPrebioticsThinnessPrebioticsbifidobacterial-ITSfunctionalitygas productionHT29in vitro modelmicrobiotaobesityprebioticsRTCASCFA

Identifiers

PMID32019174
PMCPMC7038051
OpenAlexW3003460917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.